Emsam Transdermal and Lithium Controlled-Release and Extended-Release Tablets
Determining the interaction of Emsam Transdermal and Lithium Controlled-Release and Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: selegiline
Brand name: Emsam, Eldepryl, Zelapar
Synonyms: Emsam
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Emsam Transdermal-Lithium ER
- Emsam Transdermal-Lithium Oral Solution
- Emsam Transdermal-Lithium Salts
- Emsam Transdermal-Lithium Syrup and Oral Solution
- Emsam Transdermal-Lithobid
- Emsam Transdermal-Lithostat
- Lithium Controlled-Release and Extended-Release Tablets-Emtricitabine
- Lithium Controlled-Release and Extended-Release Tablets-Emtricitabine and tenofovir
- Lithium Controlled-Release and Extended-Release Tablets-Emtricitabine and Tenofovir Alafenamide
- Lithium Controlled-Release and Extended-Release Tablets-Emtricitabine and Tenofovir Disoproxil Fumarate
- Lithium Controlled-Release and Extended-Release Tablets-Emtricitabine and Tenofovir Tablets
- Lithium Controlled-Release and Extended-Release Tablets-Emtricitabine Capsules